Add PHMMF to Watchlist?
Some Reasons Why To Add PHMMF:
  • High gross margin of 92.7%
  • Excellent financial health (Piotroski 8/9)
  • Beat earnings estimates in 3 of the last 4 quarters

PHMMF Performance

PHMMF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 25, 2025 Jun 25, 2025 Jun 27, 2025 $0.91 1.12%
2 Jun 12, 2024 Jun 12, 2024 Jun 14, 2024 $0.563 1.81%
3 Jun 07, 2023 Jun 07, 2023 Jun 07, 2023 $0.695 1.76%
4 Jul 13, 2022 Jul 13, 2022 Jul 13, 2022 $0.652 0.85%
5 Apr 28, 2021 Apr 28, 2021 Apr 28, 2021 $0.725 0.658%

FAQ

What is the symbol for Pharma Mar SA Stock and on which exchange is it traded?
The symbol for Pharma Mar SA is PHMMF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Pharma Mar SA Stock?
Pharma Mar SA holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Pharma Mar SA Stock?
Pharma Mar SA Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pharma Mar SA Stock.

What's the current price of Pharma Mar SA Stock?
As of the end of day on the Jun 23, 2026, the price of an Pharma Mar SA (PHMMF) share was $79.49.

What is the 52-week high and low for Pharma Mar SA Stock?
The 52-week high for Pharma Mar SA Stock is $110.40 and the 52-week low is $77.41.

What is the market capitalization of Pharma Mar SA Stock?
As of the Jun 23, 2026, the market capitalization of Pharma Mar SA is 1.376B.

When is the next earnings date for Pharma Mar SA?
The upcoming earnings date for Pharma Mar SA is Jul 29, 2026.
Click to get the best stock tips daily for free!
ABOUT PHARMA MAR SA
Pharma Mar SA
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ov...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE